Cargando…

Correction: Ruxolitinib sensitizes ovarian cancer to reduced dose Taxol, limits tumor growth and improves survival in immune competent mice

Detalles Bibliográficos
Autores principales: Reeves, Patrick M., Abbaslou, Mojgan A., Kools, Farah R.W., Vutipongsatorn, Kritchai, Tong, Xiaoyun, Gavegnano, Christina, Schinazi, Raymond F., Poznansky, Mark C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6084395/
https://www.ncbi.nlm.nih.gov/pubmed/30101001
http://dx.doi.org/10.18632/oncotarget.25791
_version_ 1783346170264813568
author Reeves, Patrick M.
Abbaslou, Mojgan A.
Kools, Farah R.W.
Vutipongsatorn, Kritchai
Tong, Xiaoyun
Gavegnano, Christina
Schinazi, Raymond F.
Poznansky, Mark C.
author_facet Reeves, Patrick M.
Abbaslou, Mojgan A.
Kools, Farah R.W.
Vutipongsatorn, Kritchai
Tong, Xiaoyun
Gavegnano, Christina
Schinazi, Raymond F.
Poznansky, Mark C.
author_sort Reeves, Patrick M.
collection PubMed
description
format Online
Article
Text
id pubmed-6084395
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-60843952018-08-10 Correction: Ruxolitinib sensitizes ovarian cancer to reduced dose Taxol, limits tumor growth and improves survival in immune competent mice Reeves, Patrick M. Abbaslou, Mojgan A. Kools, Farah R.W. Vutipongsatorn, Kritchai Tong, Xiaoyun Gavegnano, Christina Schinazi, Raymond F. Poznansky, Mark C. Oncotarget Correction Impact Journals LLC 2018-07-13 /pmc/articles/PMC6084395/ /pubmed/30101001 http://dx.doi.org/10.18632/oncotarget.25791 Text en Copyright: © 2018 Reeves et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (http://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Correction
Reeves, Patrick M.
Abbaslou, Mojgan A.
Kools, Farah R.W.
Vutipongsatorn, Kritchai
Tong, Xiaoyun
Gavegnano, Christina
Schinazi, Raymond F.
Poznansky, Mark C.
Correction: Ruxolitinib sensitizes ovarian cancer to reduced dose Taxol, limits tumor growth and improves survival in immune competent mice
title Correction: Ruxolitinib sensitizes ovarian cancer to reduced dose Taxol, limits tumor growth and improves survival in immune competent mice
title_full Correction: Ruxolitinib sensitizes ovarian cancer to reduced dose Taxol, limits tumor growth and improves survival in immune competent mice
title_fullStr Correction: Ruxolitinib sensitizes ovarian cancer to reduced dose Taxol, limits tumor growth and improves survival in immune competent mice
title_full_unstemmed Correction: Ruxolitinib sensitizes ovarian cancer to reduced dose Taxol, limits tumor growth and improves survival in immune competent mice
title_short Correction: Ruxolitinib sensitizes ovarian cancer to reduced dose Taxol, limits tumor growth and improves survival in immune competent mice
title_sort correction: ruxolitinib sensitizes ovarian cancer to reduced dose taxol, limits tumor growth and improves survival in immune competent mice
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6084395/
https://www.ncbi.nlm.nih.gov/pubmed/30101001
http://dx.doi.org/10.18632/oncotarget.25791
work_keys_str_mv AT reevespatrickm correctionruxolitinibsensitizesovariancancertoreduceddosetaxollimitstumorgrowthandimprovessurvivalinimmunecompetentmice
AT abbasloumojgana correctionruxolitinibsensitizesovariancancertoreduceddosetaxollimitstumorgrowthandimprovessurvivalinimmunecompetentmice
AT koolsfarahrw correctionruxolitinibsensitizesovariancancertoreduceddosetaxollimitstumorgrowthandimprovessurvivalinimmunecompetentmice
AT vutipongsatornkritchai correctionruxolitinibsensitizesovariancancertoreduceddosetaxollimitstumorgrowthandimprovessurvivalinimmunecompetentmice
AT tongxiaoyun correctionruxolitinibsensitizesovariancancertoreduceddosetaxollimitstumorgrowthandimprovessurvivalinimmunecompetentmice
AT gavegnanochristina correctionruxolitinibsensitizesovariancancertoreduceddosetaxollimitstumorgrowthandimprovessurvivalinimmunecompetentmice
AT schinaziraymondf correctionruxolitinibsensitizesovariancancertoreduceddosetaxollimitstumorgrowthandimprovessurvivalinimmunecompetentmice
AT poznanskymarkc correctionruxolitinibsensitizesovariancancertoreduceddosetaxollimitstumorgrowthandimprovessurvivalinimmunecompetentmice